Statistics for Poseida Therapeutics, (id:8196 PSTX)
Valuation metrics
Market cap
260.23M
Enterprise value
112.11M
Trailing P/E (ttm)
-1.99
Forward P/E
-1.59
PEG ratio
-1.59
Price/Sales (ttm)
1.73
Price/Book (mrq)
2.98
Enterprise Value/Revenue
0.74
Enterprise Value/EBITDA
-1.97
Overview
Shares outstanding
97.46M
Float
64.70M
Shares short
4.39M
% Held by insiders
0.28%
% Held by institutions
0.56%
Average volume (10 days)
752.97K
Average volume (90 days)
Price summary
52-Week low
1.87
52-Week high
4.27
52-Week change
0.00%
Beta
0.54
50-Day moving average
2.81
200-Day moving average
2.98
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-40.28%
Operating margin
27.52%
Operational effectiveness
Return on assets
-13.11%
Return on equity
-57.63%
Income statement
Revenue (ttm)
1.56
Revenue per share (ttm)
1.56
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-57,017,000.00
Net income to common (ttm)
-60,759,000.00
Diluted EPS (ttm)
-0.63
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
230.85M
Total cash per share (mrq)
2.37
Total debt (mrq)
82.73M
Total Debt/Equity (mrq)
94.86
Current ratio (mrq)
320.30%
Book value per share (mrq)
0.90
Cash flow
Cash flow statement
-15,023,000.00
Levered free cash flow (LFCF)
-22,237,750.00